Editas Medicine Inc (EDIT)
2.44
+0.07
(+2.95%)
USD |
NASDAQ |
Nov 22, 16:00
2.435
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Total Return Price: 2.44 for Nov. 22, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 22, 2024 | 2.44 |
| November 21, 2024 | 2.37 |
| November 20, 2024 | 2.41 |
| November 19, 2024 | 2.48 |
| November 18, 2024 | 2.52 |
| November 15, 2024 | 2.66 |
| November 14, 2024 | 2.77 |
| November 13, 2024 | 2.96 |
| November 12, 2024 | 3.07 |
| November 11, 2024 | 3.30 |
| November 08, 2024 | 3.12 |
| November 07, 2024 | 3.17 |
| November 06, 2024 | 3.28 |
| November 05, 2024 | 3.12 |
| November 04, 2024 | 2.88 |
| November 01, 2024 | 2.91 |
| October 31, 2024 | 2.90 |
| October 30, 2024 | 3.02 |
| October 29, 2024 | 3.11 |
| October 28, 2024 | 3.26 |
| October 25, 2024 | 3.18 |
| October 24, 2024 | 3.18 |
| October 23, 2024 | 3.21 |
| October 22, 2024 | 3.29 |
| October 21, 2024 | 3.76 |
| Date | Value |
|---|---|
| October 18, 2024 | 3.36 |
| October 17, 2024 | 3.31 |
| October 16, 2024 | 3.45 |
| October 15, 2024 | 3.36 |
| October 14, 2024 | 3.24 |
| October 11, 2024 | 3.19 |
| October 10, 2024 | 2.96 |
| October 09, 2024 | 3.12 |
| October 08, 2024 | 3.17 |
| October 07, 2024 | 3.21 |
| October 04, 2024 | 3.38 |
| October 03, 2024 | 3.20 |
| October 02, 2024 | 3.22 |
| October 01, 2024 | 3.27 |
| September 30, 2024 | 3.41 |
| September 27, 2024 | 3.48 |
| September 26, 2024 | 3.49 |
| September 25, 2024 | 3.39 |
| September 24, 2024 | 3.53 |
| September 23, 2024 | 3.66 |
| September 20, 2024 | 3.77 |
| September 19, 2024 | 3.91 |
| September 18, 2024 | 3.88 |
| September 17, 2024 | 3.86 |
| September 16, 2024 | 3.83 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
2.37
Minimum
Nov 21 2024
90.58
Maximum
Jan 08 2021
21.71
Average
15.52
Median
Total Return Price Benchmarks
| Ionis Pharmaceuticals Inc | 34.01 |
| EyePoint Pharmaceuticals Inc | 8.95 |
| Cassava Sciences Inc | 26.48 |
| Adverum Biotechnologies Inc | 6.04 |
| Regenxbio Inc | 9.59 |